The NICHD conducted a workshop in January 2015 to review evidence, with special consideration to avoid unnecessary treatment with antimicrobials and imprecise terminology. ACOG released a committee opinion, endorsed by SMFM, that agrees with 3 categories proposed by the workshop but differs regarding a single temperature of 39.0˚C. While the workshop included this finding under ‘isolated maternal fever’, ACOG recommends that a single temperature of 39.0˚C be placed in the ‘suspected intraamniotic infection’ category to maximize sensitivity.
Intrauterine infection can have serious complications and include sepsis, prolonged labor, PPH, hysterectomy, endometritis, ICU admission and rarely maternal mortality. Communication with neonatology team is essential. The workshop determined that research is needed in almost all aspects, including biomarkers in AF and maternal and cord blood to aid in diagnosis and treatment.
Recommended
and
Mild Penicillin Allergy
and
Severe Penicillin Allergy
and
ACOG Committee Opinion 712: Intrapartum Management of Intraamniotic Infection
ACOG Clinical Practice Update: Criteria for Suspected Diagnosis of Intraamniotic Infection
Current Management and Long-term Outcomes Following Chorioamnionitis
Maternal fever in labor: etiologies, consequences, and clinical management
Are you an
ObG Insider?
Get specially curated clinical summaries delivered to your inbox every week for free
Please log in to ObGFirst to access this page
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
It appears you don't have enough CME Hours to take this Post-Test. We no longer offer Hours.
You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site